Document is current
Any future updates will be listed below
-
Authors
Lassé, Moritz https://orcid.org/0000-0001-5735-9549
El Saghir, Jamal https://orcid.org/0000-0002-3779-4583
Berthier, Celine C. https://orcid.org/0000-0003-3539-1075
Eddy, Sean https://orcid.org/0000-0001-8578-3443
Fischer, Matthew https://orcid.org/0009-0005-7767-6089
Laufer, Sandra D. https://orcid.org/0000-0003-3177-7886
Kylies, Dominik
Hutzfeldt, Arvid https://orcid.org/0000-0001-5993-1991
Bonin, Léna Lydie https://orcid.org/0000-0002-1038-8585
Dumoulin, Bernhard
Menon, Rajasree
Vega-Warner, Virginia https://orcid.org/0009-0007-6396-6717
Eichinger, Felix
Alakwaa, Fadhl https://orcid.org/0000-0001-5349-7960
Fermin, Damian https://orcid.org/0000-0002-0548-3967
Billing, Anja M. https://orcid.org/0000-0002-5770-5496
Minakawa, Akihiro https://orcid.org/0000-0002-5683-5504
McCown, Phillip J. https://orcid.org/0000-0002-8012-1931
Rose, Michael P. https://orcid.org/0000-0001-8661-5134
Godfrey, Bradley
Meister, Elisabeth https://orcid.org/0009-0004-9730-2060
Wiech, Thorsten https://orcid.org/0000-0003-4053-1474
Noriega, Mercedes https://orcid.org/0000-0002-6701-1180
Chrysopoulou, Maria https://orcid.org/0000-0003-4502-5060
Brandts, Paul https://orcid.org/0000-0002-0649-3569
Ju, Wenjun
Reinhard, Linda https://orcid.org/0000-0001-9786-9922
Hoxha, Elion
Grahammer, Florian
Lindenmeyer, Maja T. https://orcid.org/0000-0003-4162-9107
Huber, Tobias B. https://orcid.org/0000-0001-7175-5062
Schlüter, Hartmut https://orcid.org/0000-0002-9358-7036
Thiel, Steffen https://orcid.org/0000-0002-4817-155X
Mariani, Laura H.
Puelles, Victor G. https://orcid.org/0000-0002-7735-5462
Braun, Fabian https://orcid.org/0000-0002-4742-050X
Kretzler, Matthias https://orcid.org/0000-0003-4064-0582
Demir, Fatih https://orcid.org/0000-0002-5744-0205
Harder, Jennifer L. https://orcid.org/0000-0002-7927-608X
Rinschen, Markus M. https://orcid.org/0000-0002-9252-1342
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (NIH NCATS UG3-TR-003288-01)
- License Information
-
More Information
Article History
Received: 27 September 2022
Accepted: 27 June 2023
First Online: 14 August 2023
Competing interests
: M.K. reports grants and contracts, outside of this study, through the University of Michigan with the National Institutes of Health, Chan Zuckerberg Initiative, AstraZeneca, NovoNordisk, Eli Lilly, Gilead, Goldfinch Bio, Janssen, Boehringer-Ingelheim, Moderna, European Union Innovative Medicine Initiative, Certa, Chinook, amfAR, Angion, RenalytixAI, Travere, Regeneron, IONIS and Maze Therapeutics. He has received consulting fees through the University of Michigan from Astellas, Poxel, Janssen, and UCB. M.K. serves on the NIH-NCATS council and is on the board of NephCure Kidney International. In addition, M.K. has a patent PCT/EP2014/073413 “Biomarkers and methods for progression prediction for chronic kidney disease” licensed. T.B.H. reports having consultancy agreements with AstraZeneca, Bayer, Boehringer-Ingelheim, DaVita, Fresenius Medical Care, Novartis, and Retrophin; receiving research funding from Amicus Therapeutics, Fresenius Medical Care; and being on the editorial board of Kidney International and the advisory board of Nature Review Nephrology. L.H.M. serves on the scientific advisory board for Chinook Therapeutics, Travere Therapeutics and Calliditas Therapeutics. She has grant support from Travere Therapeutics and Boeringer-Ingelheim. The other authors have no competing interests to declare.
